Abstract: A multi-temperature storage system includes a grid framework structure configured for supporting a robotic load handling device on a track system in a grid pattern of grid cells, and a supporting framework structure for supporting the track system to create a storage space with a storage columns for storage containers. A portion of the storage system is contained within an enclosure having an opening for allowing a robotic load handling device to move into and out of the enclosure. A temperature control system includes an inlet, a temperature control unit for heating or cooling the fluid to a temperature controlled fluid, and an outlet. An air curtain unit recirculates the temperature controlled fluid to provide an air curtain across the opening of the enclosure.

Abstract: An ostomy bag has an inlet leading to a waste collection space defined by two opposing surfaces of two walls. The opposing surfaces are configured to separate on the introduction of waste through the inlet and in at least one of the walls there is at least one corrugation.

Abstract: An ostomy device comprises an ostomy bag; a peristomal pad with a body-side adhesive surface and at least one belt attachment means interposed between the ostomy bag and the bag-side surface of the peristomal pad, wherein the device comprises at least one skin protection means.

Abstract: An ostomy bag including in an accessible wall 1 a closable exit aperture 5 and means 4 for selectively releasing accumulated gas through the aperture 5.

Abstract: An ostomy bag has an inlet leading to a waste collection space defined by two opposing surfaces of two walls. The opposing surfaces are configured to separate on the introduction of waste through the inlet and in at least one of the walls there is at least one corrugation.

Abstract: An ostomy device comprises an ostomy bag; a peristomal pad with a body-side adhesive surface and at least one belt attachment means interposed between the ostomy bag and the bag-side surface of the peristomal pad, wherein the device comprises at least one skin protection means.

Abstract: The invention provides a drainage bag assembly for receiving bodily waste; the drainage bag assembly comprising outer (6) and inner (12) bags secured to one side of a flange (2), the flange (2) being provided with means defining an orifice to 5 enable bodily waste to be received by the inner bag (12), and the flange (2) having connected to an opposite side thereof means for securing the drainage bag assembly to the body of a patient; the outer bag (6) being detachably secured by means of a peelable but non-repositionable adhesive to a first attachment zone (4) on the flange and the inner bag being detachably secured by means of a peelable adhesive to a 0 second attachment zone (16) on the flange, wherein the first attachment zone (4) surrounds the second attachment zone (16) and is non-overlapping therewith; and the second attachment zone (16) surrounds the means defining the orifice; and wherein the outer bag (6) can be removed or opened to permit access to the interior thereof and removal of the inner bag (

Abstract: An ostomy bag including in an accessible wall 1 a closable exit aperture 5 and means 4 for selectively releasing accumulated gas through the aperture 5.

Abstract: The invention provides an ostomy bag assembly including an outer bag and an inner bag secured to one side of a flange. The inner bag is removable to facilitate disposal. The flange has a polymeric backing film and a layer of bioadhesive for securing the ostomy bag assembly to the body of a patient. The flange includes an orifice to enable bodily waste to be received by the inner bag. The outer bag is detachably bonded to a first attachment zone on the flange and the inner bag is secured to a second attachment zone on the flange. The outer bag is mounted to the flange by an annular bonding element is formed from a multilayer polymeric material comprising first and second ethylene vinyl acetate layers and a polymeric support layer interposed there between. A method of fabricating ostomy bags is also provided.

Abstract: The invention provides an ostomy bag assembly including an outer bag and an inner bag secured to one side of a flange. The inner bag is removable to facilitate disposal. The flange has a polymeric backing film and a layer of bioadhesive for securing the ostomy bag assembly to the body of a patient. The flange includes an orifice to enable bodily waste to be received by the inner bag. The outer bag is detachably bonded to a first attachment zone on the flange and the inner bag is secured to a second attachment zone on the flange. The outer bag is mounted to the flange by an annular bonding element is formed from a multilayer polymeric material comprising first and second ethylene vinyl acetate layers and a polymeric support layer interposed there between. A method of fabricating ostomy bags is also provided.

Abstract: The invention provides an ostomy bag assembly including an outer bag and an inner bag secured to one side of a flange. The inner bag is removable to facilitate disposal. The flange has a polymeric backing film and a layer of bioadhesive for securing the ostomy bag assembly to the body of a patient. The flange includes an orifice to enable bodily waste to be received by the inner bag. The outer bag is detachably bonded to a first attachment zone on the flange and the inner bag is secured to a second attachment zone on the flange. The outer bag is mounted to the flange by an annular bonding element is formed from a multilayer polymeric material comprising first and second ethylene vinyl acetate layers and a polymeric support layer interposed there between. A method of fabricating ostomy bags is also provided.

Abstract: Compounds of structure (I): including stereoisomers and pharmaceutically acceptable salts thereof, wherein X, R1, R2, R3, R4, R5, R6 and R7 are as defined herein. Such compounds have activity as SHIP1 modulators, and thus may be used to treat any of a variety of diseases, disorders or conditions that would benefit from SHIP1 modulation. Compositions comprising a compound of structure (I) in combination with a pharmaceutically acceptable carrier or diluent are also disclosed, as are methods of SHIP1 modulation by administration of such compounds to an animal in need thereof.

Abstract: The invention provides a drainage bag assembly for receiving bodily waste; the drainage bag assembly comprising outer (6) and inner (12) bags secured to one side of a flange (2), the flange (2) being provided with means defining an orifice to enable bodily waste to be received by the inner bag (12), and the flange (2) having connected to an opposite side thereof means for securing the drainage bag assembly to the body of a patient; the outer bag (6) being detachably secured by means of a peelable but non-repositionable adhesive to a first attachment zone (4) on the flange and the inner bag being detachably secured by means of a peelable adhesive to a second attachment zone (16) on the flange, wherein the first attachment zone (4) surrounds the second attachment zone (16) and is non-overlapping therewith; and the second attachment zone (16) surrounds the means defining the orifice; and wherein the outer bag (6) can be removed or opened to permit access to the interior thereof and removal of the inner bag (12).

Abstract: Compounds of structure (I): including stereoisomers and pharmaceutically acceptable salts thereof, wherein X, R1, R2, R3, R4, R5, R6 and R7 are as defined herein. Such compounds have activity as SHIP1 modulators, and thus may be used to treat any of a variety of diseases, disorders or conditions that would benefit from SHIP1 modulation. Compositions comprising a compound of structure (I) in combination with a pharmaceutically acceptable carrier or diluent are also disclosed, as are methods of SHIP1 modulation by administration of such compounds to an animal in need thereof.

Abstract: The invention provides an ostomy bag assembly including an outer bag and an inner bag secured to one side of a flange. The inner bag is removable to facilitate disposal. The flange has a polymeric backing film and a layer of bioadhesive for securing the ostomy bag assembly to the body of a patient. The flange includes an orifice to enable bodily waste to be received by the inner bag. The outer bag is detachably bonded to a first attachment zone on the flange and the inner bag is secured to a second attachment zone on the flange. The outer bag is mounted to the flange by an annular bonding element is formed from a multilayer polymeric material comprising first and second ethylene vinyl acetate layers and a polymeric support layer interposed there between. A method of fabricating ostomy bags is also provided.

Abstract: Antibacterial 3-aminoquinazolin-2,4-diones have formula (I) wherein: R1 and R3 include alkyl, alkenyl, alkynyl, cycloalkyl, aryl, heterocyclic, and heteroaryl; R5, R6, and R8 include H, alkyl, alkoxy, halo, NO2, CN, NH2, alkyl and dialkylamino; R7 includes hydrogen, alkyl, cycloalkyl, heterocyclic, fused heterocyclic, aryl and fused aryl; J and K are C or N; and pharmaceutically acceptable salts thereof.

Abstract: An odor adsorbing or deodorizing filter which comprises a matrix or substrate impregnated with a mixture of particulate chemically modified activated carbon and particulate activated carbon, together with a binder. The filter may be incorporated into an ostomy collection bag, wound dressing, respirator, air conditioning unit or the like.

Abstract: A method, computer program product, and system for controlling access to elements in a database object are provided. The method, computer program product, and system provide for receiving a request from a user to access the database object, determining whether an access restriction is imposed on the database object, and controlling access to the elements in the database object by the user based on the access restriction. The access restriction specifies one or more users to which the access restriction is applicable, defines a dynamic condition the one or more users must satisfy in order to access the database object, and identifies one or more of the elements in the database object accessible to the one or more users when the dynamic condition is satisfied.

Abstract: Antibacterial 3-aminoquinazolin-2,4-diones have formula (1) wherein: R1 and R3 include alkyl, alkenyl, alkynyl, cycloalkyl, aryl, heterocyclic, and heteroaryl; R5, R6, and R8 include H, alkyl, alkoxy, halo, NO2, CN, NH2, alkyl and dialkylamino; R7 includes hydrogen, alkyl, cycloalkyl, heterocyclic, fused heterocyclic, aryl and fused aryl; J and K are C or N; and pharmaceutically acceptable salts thereof.

Abstract: An apparatus, a method and a computer program product for releasing a nested savepoint on a remote node of a database management system. The to-be-released savepoint is one of a series of savepoints represented by control blocks arranged in a linked list in the creation order of the savepoints they represent. Releasing of the to-be-released savepoint begins with receiving of a request to release the to-be-released savepoint. A control block is selected such that it represents the to-be-released savepoint or the next more recently created savepoint after the to-be-released savepoint. The selected control block is merged with all other control blocks that represent savepoints that are more recently created than the savepoint represented by the selected control block. The resulting merged control block represents all of the savepoints from the most recently created to the savepoint previously represented by the selected control block.